Skip to main content

Table 3 Antimicrobial susceptibility pattern of ESBL producing Entrobacteriaceae isolated from the hospital environment at the University of Gondar Referral Hospital, northwest Ethiopia, and January–June 2014

From: Prevalence and antimicrobial susceptibility patterns of extended spectrum beta-lactamase producing Entrobacteriaceae in the University of Gondar Referral Hospital environments, northwest Ethiopia

Organism

Pattern

Antimicrobial agent’s N (%)

CFP (N, %)

CPD (N, %)

CAZ (N, %)

CTR (N, %)

CIP (N, %)

NX (N, %)

GEN (N, %)

C (N, %)

AMC (N, %)

SXT (N, %)

E. coli

S

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

14 (70.0)

15 (75.0)

16 (80.0)

9 (45.0)

0 (0.0)

13 (65.0)

R

20 (100)

20 (100)

20 (100)

20 (100)

6 (30.0)

5 (25.0)

4 (20.0)

11 (55.0)

20 (100)

7 (35.0)

K. pneumonia

S

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

13 (54.2)

13 (54.2)

18 (75.0)

8 (33.3)

0 (0.0)

2 (8.3)

R

24 (100)

24 (100)

24 (100)

24 (100)

11 (45.8)

11 (45.8)

6 (25.0)

16 (66.7)

24 (100)

22 (91.7)

K. ozenae

S

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

2 (100.0)

2 (100.0)

2 (100.0)

0 (0.0)

0 (0.0)

0 (0.0)

R

2 (100)

2 (100)

2 (100)

2 (100)

0 (0.0)

0 (0.0)

0 (0.0)

2 (100)

2 (100)

2 (100)

P. mirabilis

S

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

3 (75.0)

3 (75.0)

4 (100)

0 (0.0)

0 (0.0)

2 (50.0)

R

4 (100)

4 (100)

4 (100)

4 (100)

1 (25.0)

1 (25.0)

0 (0.0)

4 (100)

4 (100)

2 (50.0)

E. cloace

S

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (100)

0 (0.0)

0 (0.0)

0 (0.0)

R

1 (100)

1 (100)

1 (100)

1 (100)

1 (100)

1 (100)

0 (0.0)

1 (100)

1 (100)

1 (100)

E. aerogens

S

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

2 (100)

0 (0.0)

0 (0.0)

0 (0.0)

R

2 (100)

2 (100)

2 (100)

2 (100)

2 (100)

2 (100)

0 (0.0)

2 (100)

2 (100)

2 (100)

Citrobacter

S

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

2 (100)

0 (0.0)

0 (0.0)

0 (0.0)

R

2 (100)

2 (100)

2 (100)

2 (100)

2 (100)

2 (100)

0 (0.0)

2 (100)

2 (100)

2 (100)

P. stuart

S

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (50.0)

0 (0.0)

0 (0.0)

0 (0.0)

R

2 (100)

2 (100)

2 (100)

2 (100)

2 (100)

2 (100)

1 (50.0)

2 (100)

2 (100)

2 (100)

Total (57)

S

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

32 (56.1)

33 (57.9)

46 (80.7)

18 (31.6)

0 (0.0)

17 (29.8)

R

57 (100)

57 (100)

57 (100)

57 (100)

25 (43.9)

24 (42.1)

11 (19.3)

39 (68.4)

57 (100)

40 (70.2)

  1. CFP cefpirome, CPD cefpodoxime, CAZ ceftazidime, CTR ceftriaxone, CIP ciprofloxacin, NX norfloxacin, GEN gentamycin, C chloramphenicol, SXT sulfamethoxazole + trimethoprim (cotrimoxazole), AMC amoxicillin with clavulanic acid, S sensitive, R resistance